Immunosenescence and Vaccinations in the Elderly

被引:8
作者
Hutt, Hans Joachim [1 ]
Bennerscheidt, Petra [1 ]
Thiel, Britta [1 ]
Arand, Manuela
机构
[1] Sanofi Pasteur MSD GmbH, Leimen, Germany
关键词
Vaccination; Immunosenescence; Influenza; Pneumococci; Intradermal vaccine; PNEUMOCOCCAL POLYSACCHARIDE VACCINE; ANTIBODY PERSISTENCE; SAFETY; DELIVERY; ADULTS; OLDER; IMMUNOGENICITY; INFLUENZA; IMMUNITY;
D O I
10.1007/s00063-010-1137-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
With increasing age, infection-induced morbidity and mortality rises. At the same time, the protective capacity of the immune system declines. This phenomenon is known as immunosenescence. It concerns all parts of the immune system and leads to a decline of cellular and humoral immune defense. As a consequence, the ability to resist infections and the immune response to vaccinations could be impaired. In order to protect senior citizens effectively against infections with dangerous pathogens like influenza viruses or pneumococci, new immunisation strategies, e.g. with shortened intervals between vaccinations, new vaccines or new vaccination techniques are required. Intradermal vaccines seem to be a promising approach, for instance. At the same time the acceptance of vaccination ought to be increased in the senior age group. Physicians, especially general practitioners play an important role because of their decisive effect on the willingness of the population to get vaccinated.
引用
收藏
页码:802 / 807
页数:6
相关论文
共 27 条
  • [1] *AGI, AGI ABSCHL INFL 2007
  • [2] [Anonymous], 2010, IMPFPLAN 2010 OSTERR
  • [3] Intradermal influenza vaccine for older adults: A randomized controlled multicenter phase III study
    Arnou, Robert
    Icardi, Giancarlo
    De Decker, Marijke
    Ambrozaitis, Arvydas
    Kazek, Marie-Pierre
    Weber, Francoise
    Van Damme, Pierre
    [J]. VACCINE, 2009, 27 (52) : 7304 - 7312
  • [4] Aspinall R, 2007, IMMUN AGEING, V4, P1
  • [5] Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults A placebo-controlled trial
    Beytout, Jean
    Launay, Odile
    Guiso, Nicole
    Fiquet, Anne
    Baudin, Martine
    Richard, Patrick
    Baptiste, Charles
    Soubeyrand, Benoit
    [J]. HUMAN VACCINES, 2009, 5 (05): : 315 - 321
  • [6] Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons
    Blank, Patricia R.
    Schwenkglenks, Matthias
    Szucs, Thomas D.
    [J]. BMC PUBLIC HEALTH, 2008, 8 (1)
  • [7] Centers for Disease Control (CDC), 1988, MMWR Morb Mortal Wkly Rep, V37, P657
  • [8] Additive preventive effect of influenza and pneumococcal vaccines in elderly persons
    Christenson, B
    Hedlund, J
    Lundbergh, P
    Örtqvist, Å
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (03) : 363 - 368
  • [9] Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects
    Couch, Robert B.
    Winokur, Patricia
    Brady, Rebecca
    Belshe, Robert
    Chen, Wilbur H.
    Cate, Thomas R.
    Sigurdardottir, Bryndis
    Hoeper, Amy
    Graham, Irene L.
    Edelman, Robert
    He, Fenhua
    Nino, Diane
    Capellan, Jose
    Ruben, Frederick L.
    [J]. VACCINE, 2007, 25 (44) : 7656 - 7663
  • [10] Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681